Latent Tuberculosis Infection Detection Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market – (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Latent Tuberculosis Infection Detection Market is valued at US$ 1.53 Bn in 2023, and it is expected to reach US$ 2.37 Bn by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2579

Latent Tuberculosis Infection (LTBI) is characterized by the presence of Mycobacterium tuberculosis in individuals who do not exhibit active disease symptoms. Accurate identification of LTBI is essential for preventing the progression to active tuberculosis (TB). The LTBI diagnostic market is experiencing growth driven primarily by the rising risk of active TB development and increased public awareness regarding the importance of early TB detection. Key factors contributing to market expansion include the growing aging population and the higher prevalence of tuberculosis among older adults. Additionally, a heightened focus on early diagnosis and tuberculosis risk mitigation is expected to further stimulate market demand.

Government-led initiatives aimed at enhancing tuberculosis awareness and the introduction of innovative diagnostic technologies are anticipated to play a significant role in market growth during the forecast period. The market comprises the manufacturing and distribution of diagnostic tests specifically designed for the detection of latent tuberculosis infections. Given the global burden of tuberculosis and the critical need for early intervention, LTBI detection has become a focal point within public health strategies.